Once-Weekly Semaglutide with Lifestyle Intervention Results in Clinically Significant Weight Loss

J Gen Intern Med. 2022 May;37(7):1824-1826. doi: 10.1007/s11606-021-07215-4. Epub 2022 Mar 1.

Authors

Rachel S Chang¹, Jiun-Ruey Hu², Hsin-Chieh Yeh³

Affiliations

¹ Vanderbilt University School of Medicine, Vanderbilt University Medical Center, 2209 Garland Ave, Nashville, TN, 37232, USA. [email protected].
² Department of Internal Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.
³ Department of Medicine, Johns Hopkins University, 2024 E. Monument St., Suite 2-500, Baltimore, MD, 21205, USA.

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucagon-Like Peptides*
Glycated Hemoglobin / analysis
Humans
Hypoglycemic Agents
Life Style
Weight Loss

Substances

Glycated Hemoglobin A
Hypoglycemic Agents
semaglutide
Glucagon-Like Peptides